News
Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.
Latest Coverage
30 headlines
In silico modeling predicts robust AP01 distribution in healthy and fibrotic lungs, even in severe diseasePatient survey findings suggest that clear communication, transparent discussions of potential benefits and
Liberty Global (NASDAQ: LBTYA, LBTYB and LBTYK) today announced that it has agreed to sell VodafoneZiggo's tower assets to an entity to be jointly owned by funds managed by DigitalBridge, TD Greystone Infrastructure
Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ:LUCY, LUCYW))), the developer and manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Nautica® and Eddie Bauer®
BMO Capital analyst Jeffrey Silber initiates coverage on Andersen Group (NYSE:ANDG) with a Market Perform rating and announces Price Target of $58.
Aduro Clean Technologies Inc. ("Aduro" or the "Company") (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste
Johnson & Johnson (NYSE:JNJ) today announced that 24 abstracts featuring clinical data and real-world evidence across the neuropsychiatry portfolio will be presented at the 2026 Psych Congress Annual Meeting
https://www.wsj.com/finance/currencies/robinhood-strikes-deal-with-crypto-com-in-latest-prediction-markets-push-901a32aa
Filed: 2026-09-08 AccNo: 0001636282-26-000113 Size: 237 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Baird analyst Colin Sebastian maintains Airbnb (NASDAQ:ABNB) with a Outperform and raises the price target from $175 to $200.
Rigetti Computing (RGTI) stock jumped 6% premarket after securing $100M in U.S. CHIPS Act funding for quantum computing R&D. Read more.
Analysts initiated coverage with Buy ratings on SpaceX, Securitize ; Overweight on Londian Wason.
U.S. stock futures fell as Novartis plunged 12.7% after pelacarsen’s Phase III trial missed its endpoint; other biotech stocks also declined.
Novartis stock falls following Phase 3 clinical trial failures for del-desiran and pelacarsen, impacting Ionis and Royalty Pharma shares.
Filed: 2026-09-08 AccNo: 0001477932-26-005436 Size: 155 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0001493152-26-041704 Size: 6 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0001213900-26-097851 Size: 187 KB Item 8.01: Other Events
Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it will present
Filed: 2026-09-08 AccNo: 0001437749-26-029755 Size: 163 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0001193125-26-384403 Size: 212 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0001193125-26-384402 Size: 425 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events
Options markets are pricing big earnings moves for nine stocks, led by AeroVironment, American Eagle, RH, Oracle and other major names.
Filed: 2026-09-08 AccNo: 0001193125-26-384405 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Hovde Group analyst Brett Rabatin initiates coverage on Northrim BanCorp (NASDAQ:NRIM) with a Outperform rating and announces Price Target of $30.
Filed: 2026-09-08 AccNo: 0001628280-26-060809 Size: 311 KB Item 8.01: Other Events
China Renaissance analyst Jack Zhou initiates coverage on Corning (NYSE:GLW) with a Buy rating and announces Price Target of $238.